CASE REPORT
Accepted on 17 Feb 2025
Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma: a case report
doi 10.3389/fimmu.2025.1528198
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
1,432
Total downloads
4,749
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 07 Feb 2025
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
doi 10.3389/fonc.2025.1508682
- 164 views
ORIGINAL RESEARCH
Published on 27 Jan 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma
doi 10.3389/fimmu.2025.1530262
- 505 views
ORIGINAL RESEARCH
Published on 31 Oct 2024
Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma
doi 10.3389/fimmu.2024.1466310
- 756 views
ORIGINAL RESEARCH
Published on 01 Oct 2024
Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
doi 10.3389/fonc.2024.1460150
- 1,041 views
MINI REVIEW
Published on 12 Jun 2024
Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma
doi 10.3389/fonc.2024.1430684
- 876 views
Published in
Frontiers in Oncology
- Molecular and Cellular Oncology
Impact
- 4,749Topic views
- 2,850Article views
- 1,432Article downloads